Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2005
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/07/2005CA2538574A1 4-(1-benzofuran-3-yl-methylideneaminoxy.propoxy))-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairment of the fibrinolytic system andof thrombosis
04/07/2005CA2536791A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics
04/06/2005EP1519930A1 Benzoprostacyclin intermediates and methods for their preparation
04/06/2005EP1519726A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity
04/06/2005EP0944310B1 Stabilized ascorbyl compositions
04/06/2005CN1603317A Process for preparation of 4-phenylacetylene phthalic anhydride
04/06/2005CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/06/2005CN1195749C Method for the preparation of 5-cyanophthalide
04/06/2005CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
04/06/2005CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
04/05/2005US6875884 Urea derivatives as inhibitors for CCR-3 receptor
04/05/2005US6875780 Compounds that modulate PPAR activity and methods for their preparation
04/05/2005US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same
04/05/2005US6875760 Glucagon antagonists/inverse agonists
03/2005
03/31/2005WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
03/31/2005WO2005028409A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
03/31/2005WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
03/31/2005WO2004073606A3 Sulfonamide derivatives as ppar modulators
03/31/2005WO2003073987A3 Compounds that modulate the activity of ptp-1b and tc-ptp
03/31/2005US20050070710 Triarylamine containing monomers for optoelectronic devices
03/31/2005US20050070598 Using 4-oxot perhydro( furan or pyran)-3-yl carbamoyl derivative; bone disorders; oral disease; antiarthritic agents
03/31/2005US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders
03/31/2005US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/31/2005US20050067951 For example, N,N'-bis-(4'-(N-triphenylmethyl)-phenyl)-N-naphth-1-yl-amino)-bi-phenylyl)-N,N'-bisphenyl-2,7-amino-9-phenylcarbazole; hole transfer material
03/31/2005CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/30/2005EP1517974A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
03/30/2005EP1517908A2 Novel benzimidazole derivatives
03/30/2005EP1517902A2 Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compositions
03/30/2005EP1517886A1 Novel phthalamide derivatives
03/30/2005EP1517885A2 Aminoacetonitrile derivatives suitable for controlling parasites
03/30/2005EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
03/30/2005EP1517879A1 Aminoalkylphenols, methods of using and making the same
03/30/2005EP1517748A1 Titaniun-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005EP1444197B1 Novel phenyl-propargylether derivatives
03/30/2005EP1302469B1 Process for producing hydroxylactone
03/30/2005EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease
03/30/2005EP0877740B1 Thiol derivatives with metallopeptidase inhibitory activity
03/30/2005CN1602306A Preparation of trans-fused 3, 3a, 8, 12b-tetrahydro-2h-dibenzo[3, 4:6, 7]cyclohepta[1, 2-b]furan derivatives
03/30/2005CN1602305A Method for the preparation of escitalopram
03/30/2005CN1602304A Deuterated substituted dihydrofuranones and medicaments containing these compounds
03/30/2005CN1602293A Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1600782A Polyalkylbicyclic derivatives
03/30/2005CN1600772A Aryl phenyl substituted cyclic ketoenols
03/30/2005CN1194985C Diterpene compound of veronicastrum sibiricum and its extraction separation method
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872839 Stabilizers; heat resistance, colorfastness, photostability
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005CA2268870C Heterocyclic carboxamides
03/24/2005WO2005027157A2 Salt fusible at ordinary temperature and electrochemical device
03/24/2005WO2005026231A1 Polymer complex compound and polymeric luminescent element employing the same
03/24/2005WO2005026141A2 Process for preparation of substituted butenolides via palladium-free etherification and amination of masked mucohalic acids
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2005005456A3 Peptide deformylase inhibitors
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065338 Total synthesis of galanthamine, analogues and derivatives thereof
03/24/2005US20050065209 Citalopram for the treatment of elevated blood pressure
03/24/2005US20050065208 Benzofuranes and their use in the treatment of atrial fibrillation
03/24/2005US20050065207 Method for the preparation of escitalopram
03/24/2005US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin
03/24/2005US20050065096 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1516878A1 Refreshment capable of stimulating movement of digestive tract
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1515956A1 Peptide deformylase inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005EP1289977B1 Triterpenoid derivatives and their use as antiproliferative agents
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599716A Aminoacetonitrile derivatives and their use for controlling parasites
03/23/2005CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
03/23/2005CN1597676A Jujube kernel saponin derivative and its preparation method and use
03/23/2005CN1597235A New use of 4-(4-mothyl-n-amyl) cyclohexane-1, 2-diacid anhydride
03/23/2005CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
03/23/2005CN1193975C Two- stage process for hydrogenation of maleic acid to 1.4-butanediol
03/23/2005CN1193974C Method for catalystically producing organic substances by partial oxidation
03/22/2005US6869972 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023791A2 Process for the production of mycophenolate mofetil
03/17/2005WO2005023764A1 Salt of atorvastatin with ranitidine
03/17/2005WO2005023737A1 Process for the hydrogenation of esters of alpha-substituted carboxylic acids
03/17/2005WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005WO2005023183A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
03/17/2005WO2005023182A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/17/2005WO2004106315A3 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 472